Stay updated on Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-18T02:15:11.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer displays an updated site revision number.
    Difference
    0.0%
    Check dated 2026-10-11T03:02:25.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry labeled v3.7.0, indicating the page was updated to that version. The prior v3.6.6 entry is removed from the current diff view.
    Difference
    0.0%
    Check dated 2026-09-20T01:26:25.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.6.6, replacing v3.6.5, signaling an update to the page’s revision log.
    Difference
    0.0%
    Check dated 2026-08-29T19:39:24.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The References item in the Study Record Versions navigation was removed, reducing quick access to the study's cited sources in history views. This affects how users review citations and source materials across historical versions.
    Difference
    0.0%
    Check dated 2026-08-15T19:52:40.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The revision tag on the study history page updated from v3.6.4 to v3.6.5, indicating a new version of the page rendering.
    Difference
    0.0%
    Check dated 2026-08-08T17:19:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.